Fact CheckerSign in

NCT05879549Completed

Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With Hemophilia

Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises in Improving Balance and Gait in Patient With Hemophilia

Source: ClinicalTrials.gov · Last updated 25 Jun 2025

Brief summary (registry, in English)

Hemophilia is a bleeding disorder caused by a deficiency of clotting factors in the blood. Muscle and joint bleeding are frequently observed in patients with hemophilia. Lower extremity bleeding can adversely affect balance, gait, and proprioception. The goal of this study; To compare the effectiveness of closed kinetic chain exercises and proprioceptive exercises on balance, proprioception and gait parameters in adolescent and young hemophilic individuals with lower extremity joint involvement. The main question it aims to answer is: Are the effects of closed kinetic chain exercises and proprioceptive exercises different on balance and walking in hemophilic individuals?

Status (registry)
Completed
Study type
Interventional
Enrollment
46 (actual)
First submitted
5 May 2023
Start date
15 Nov 2023
Primary completion date
30 Mar 2024
Lead sponsor
Bahçeşehir University
Diseases
Haemophilia
NCT number
NCT05879549

What you commit to

  • Study type: Interventional
  • Participants enrolled: 46
  • From 15 Nov 2023 to the primary completion date, 30 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having undergone lower extremity surgery in the last 6 months
  • Have an inhibitor

Other

  • Having a Body Mass Index over 30 kg/m2
  • Using a walking aid

Who the study is looking for

  • Having been diagnosed with Hemophilia A and Hemophilia B
  • Having a blood factor level below 5%,
  • Between 13-25 years old
  • History of bleeding to the lower extremity and target joint
  • Total lower extremity Hemophilia joint health score ≥3
  • Using prophylaxis

Age in the registry: 13 years to 25 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
İstanbul University-Cerrahpaşa
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.